CENBF (CEN Biotech) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CEN Biotech Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

CEN Biotech Quality Rank Related Terms

CEN Biotech Business Description

Address 3295 Quality Way, Suite 300, Windsor, ON, CAN, N8T 3R9
CEN Biotech Inc. was a Canadian company that sought to operate in the regulated medical cannabis industry. Through its subsidiary Creative Edge Nutrition, it pursued licensing under Canada's Marijuana for Medical Purposes Regulations to cultivate and sell pharmaceutical-grade medical cannabis to registered patients. The company was based in Lakeshore, Ontario, and its business model centered on producing and distributing medical marijuana directly to patients authorized under the federal program. CEN Biotech never obtained the required Health Canada license to produce or sell cannabis, and its operations were subject to regulatory scrutiny and legal proceedings. The company's shares traded on US over-the-counter markets under the ticker CENBF. Its plans to generate revenue from medical cannabis sales were never realized, and the enterprise effectively ceased active operations.